US Patent Issued to Iovance Biotherapeutics on Feb. 18 for "Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy" (Pennsylvania, California Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,230,378, issued on Feb. 18, was assigned to Iovance Biotherapeutics Inc. (San Carlos, Calif.).

"Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy" was invented by Anne Brooks (Downingtown, Pa.), Steve Macrides (West Chester, Pa.) and Kristin Lanzi (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for coordinating the manufacturing of an expanded cell therapy product for a patient may include receiving a cell order request to expand the cell therapy product for the patient; generating a patient-specific identifier or cell order identifier associated with the cell order request; and initiat...